Clinical trial
Weekly TP-HDFL in the Treatment of Advanced TCC
NCT00154687 · National Taiwan University Hospital, Other · Completed
Key facts
| NCT number | NCT00154687 |
|---|---|
| Title | Weekly TP-HDFL in the Treatment of Advanced TCC |
| Official title | A Phase II Study of Weekly Paclitaxel, Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin(Weekly TP-HDFL) in the Treatment of Advanced Transitional Cell Carcinoma(TCC) |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Transitional Cell Carcinoma |
| Intervention type | Drug |
| Interventions | Paclitaxel, Cisplatin, 5-Fluorouracil |
| Enrollment | 40 |
| Start date | Oct 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Jul 31, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: